![2-Methyl-2,7-diaza-spiro[4.4]nonane](https://static.cymitquimica.com/cas-image/151146-2-methyl-27-diaza-spiro-4-4-nonane.png)
CAS: 135380-53-9 - 2-Methyl-2,7-diaza-spiro[4.4]nonane
Fórmula:C8H16N2
InChI:InChI=1/C8H16N2/c1-10-5-3-8(7-10)2-4-9-6-8/h9H,2-7H2,1H3
- Sinónimos:
- 2-Methyl-2,7-Diazaspiro[4.4]Nonane
- 8-Methyl-3,8-Diazaspiro[4.4]Nonane
- 2,7-Diazaspiro[4.4]Nonane, 2-Methyl-
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 2,7-DIAZASPIRO[4.4]NONANE, 2-METHYL- REF: IN-DA009DUXCAS: 135380-53-9 | 95% | 166,00 €~491,00 € | Mar 26 Nov 24 |
 | 2-Methyl-2,7-diazaspiro[4.4]nonane REF: 10-F600340CAS: 135380-53-9 | 97% | 189,00 €~699,00 € | Mié 27 Nov 24 |
 | 2-Methyl-2,7-diazaspiro[4.4]nonane REF: 3D-KFA38053CAS: 135380-53-9 | Min. 95% | A consultar | Mar 07 Ene 25 |
![2,7-DIAZASPIRO[4.4]NONANE, 2-METHYL-](https://static.cymitquimica.com/products/IN/thumb/DA009DUX.jpg)
2,7-DIAZASPIRO[4.4]NONANE, 2-METHYL-
CAS:135380-53-9
Fórmula:
C8H16N2
Pureza:
95%
Forma y color:
Liquid
Peso molecular:
140.2260
Ref: IN-DA009DUX
| 1g | 491,00 € | ||
| 100mg | 166,00 € | ||
| 250mg | 212,00 € |
Entrega estimada en Estados Unidos, el Martes 26 de Noviembre de 2024
![2-Methyl-2,7-diazaspiro[4.4]nonane](https://static.cymitquimica.com/products/10/thumb/F600340.jpg)
2-Methyl-2,7-diazaspiro[4.4]nonane
CAS:135380-53-9
Pureza:
97%
Forma y color:
Liquid
Peso molecular:
140.22999572753906
Ref: 10-F600340
| 1g | 699,00 € | ||
| 100mg | 189,00 € | ||
| 250mg | 304,00 € |
Entrega estimada en Estados Unidos, el Miércoles 27 de Noviembre de 2024
![2-Methyl-2,7-diazaspiro[4.4]nonane](https://static.cymitquimica.com/products/3D/thumb/KFA38053.jpg)
2-Methyl-2,7-diazaspiro[4.4]nonane
CAS:135380-53-9
2-Methyl-2,7-diazaspiro[4.4]nonane is a substance that has been found to inhibit the production of proteins that …
Fórmula:
C8H16N2
Pureza:
Min. 95%
Peso molecular:
140.23 g/mol
Ref: 3D-KFA38053
| 50mg | 298,00 € | ||
| 500mg | 1.119,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
